Chief Medical Officer Careers

The firm is an emerging biotechnology company focusing on discovering, developing, and commercializing therapies that harness the body’s natural protein disposal system to selectively degrade and remove disease-causing proteins.

By developing engineered diabodies and antibody conjugates that activate or inhibit the targeted cell mechanism(s), this innovative, start-up biotech is focused on disease areas that include anemia and phosphate wasting. disorders.

The company is an established biotech. This opportunity will lead the global strategy and development of an expansive portfolio across several therapeutic areas.

A clinical-stage biopharmaceutical company is seeking a Chief Medical Officer to lead its clinical and medical strategy. The company is advancing a novel small-molecule therapeutic candidate targeting multiple neurodegenerative conditions including Alzheimer’s and Parkinson’s disease.

The business is a start-up biotechnology company focusing on rare metabolic disease whose lead asset has just recently initiated clinical trials.

The firm is a leading precision medicine company developing AI tests to personalize cancer therapy.

The company is a preclinical stage biotech who has just successfully achieved their Series A funding with a focus in the discovery and development of new therapies within immunology and inflammation.

The firm is a US based clinical-stage specialty pharmaceutical company charged with developing inhaled drug/biologic and device combination products that will transform the standard of care for acute and critically ill patients.

The firm is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) disorders, infectious diseases, immunology conditions, and rare diseases with high unmet medical need.

The company is a leading provider of diagnostic information services and is currently searching for a Chief Medical Officer (CMO) for Health Systems and Strategic Partnerships.

The firm is a well-capitalized, stealth-stage biotechnology company that is building a differentiated therapeutic platform with the potential to address significant unmet needs with an initial focus on rare disease.

A well-established and rapidly growing Federally Qualified Health Center (FQHC) serving diverse communities in Metro California is seeking a visionary Chief Medical Officer (CMO).

The entity is a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other autoimmune diseases.

The organization is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders.

The Corporate entity is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases.

The company is global leader in the discovery, development and commercialization of mRNA therapeutics.

The corporate entity is a purpose-driven, commercial-stage biotechnology company with a late-stage pipeline committed to redefining what is possible in bringing life-changing therapies to people living with rare diseases.

The firm is a well-capitalized, stealth-stage biotechnology company that is building a differentiated therapeutic platform with the potential to address significant unmet needs.

The firm is a biologics innovation company dedicated to developing advanced biotherapeutics with AI-powered solutions.

The organization is a European-headquartered, commercial-stage biotechnology company that specializes in the development and commercialization of innovative orthobiologics for tissue repair and spinal bone regeneration.